Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimal-dose S-ketamine for postoperative analgesia after minimally invasive radical esophagectomy
ChiCTR2100048311Phase 4Completed
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in postoperative pain (2 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoint: Cumulative opioid consumption in the first 48 hours postoperatively. Started Jan 2022; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100048311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048311.